Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fortune eupatorium, known as Peilan in Traditional Chinese Medicine (TCM), is a botanical drug derived from the aerial parts of *Eupatorium fortunei* Turcz. It is characterized by its aromatic properties, which are primarily attributed to its volatile oil content, including compounds such as p-cymene, n-octyl aldehyde, and coumarin. In TCM, it is classified as an aromatic herb that resolves dampness, awakens the spleen, and clears summer-heat. Clinically, it is indicated for conditions involving dampness obstructing the middle burner, characterized by symptoms such as nausea, vomiting, loss of appetite, and a greasy tongue coating. It is also traditionally used to treat halitosis and early-stage summer-heat dampness syndrome.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fortune eupatorium.